Peer Review History

Original SubmissionMarch 9, 2022
Decision Letter - Mehdi Rahimi, Editor

PONE-D-22-06916First assessment of Iranian pomegranate germplasm using targeted metabolites and morphological traits to develop the core collection and modeling of the current and future spatial distribution under climate change conditionsPLOS ONE

Dear Dr. Zeinalabedini,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 21 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mehdi Rahimi, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following financial disclosure: 

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. 

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. Thank you for stating the following in your Competing Interests section:  

I have read the journal's policy and the authors of this manuscript have the following competing interests

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now 

 This information should be included in your cover letter; we will change the online submission form on your behalf.

5. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

6. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

7. We note that Figures 1-3 and 13-14 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figures 1-3 and 13-14 to publish the content specifically under the CC BY 4.0 license.  

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

Additional Editor Comments:

Dear Authors

Below, please find the reviewers' comments for your paper. You have carried out the corrections as suggested by the reviewer(s).

with Thanks

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Manuscript titled:

First assessment of Iranian pomegranate germplasm using targeted metabolites and morphological traits to develop the core collection and modeling of the current and future spatial distribution under climate change conditions

There are several linguistic and typographical mistakes in this paper that must be corrected.

1. What is novelty in the abstract? It needs improvement

2. Reference should be according to journal format

3. The manuscript must revise with native English speakers because the manuscript contains a lot of mistakes in grammar and structure, for example, Line 302

“The analysis of Spearman coefficient of correlation between morphological and metabolite traits was showed antioxidant activity correlated positively with total phenol”. Rephrase sentence.

4. Line 312. “also reported there was a negative correlation”. Rephrase the sentence.

5. The discussion section is just descriptive of the results, there are no logical reasoning. Give some recent and comprehensive literature in discussion and support the obtained results. Do not give simple biological inference.

6. Do add the following latest references in discussion part for justification of your results, please.

Zarei A (2017). Biochemical and pomological characterization of pomegranate accessions in fars province of Iran. SABRAO J. Breed. Genet. 49(2): 155–167.

Tarinta T, Chanthai S, Lertrat K, Nawata E, Techawongstien S (2020). Identification of the secondary metabolite capsiate in Capsicum germplasm accessions. SABRAO J. Breed. Genet. 52(2):144–157.

Upadyshev MT (2022). Apple cultivars and rootstocks assay for the identification of diverse viruses and healthy genotypes for breeding. SABRAO J. Breed. Genet. 54(1): 79-87. http://doi.org/10.54910/sabrao2022.54.1.8.

Motyleva SM, Medvedev SM, Morozova NG, Kulikov IM (2021). Leaf micromorphological and biochemical features of scab disease in immune and moderately resistant columnar apple (Malus domestica) cultivars. SABRAO J. Breed. Genet. 53(3): 352-366.

Hong-Qun, L. I., Li-Gang, X. I. N. G., & Xie-Ping, S. U. N. (2022). Predicting the potential distribution of Taxus wallichiana var. Mairei under climate change in China using maxent modeling. Pak. J. Bot. 54(4): 1305-1310.

Ahmad, N., Shakil, A., Shinwari, Z. K., Ahmad, I., & Wahab, A. (2022). Phytochemical study and antimicrobial activities of extracts and its derived fractions obtained from Berberis vulgaris L. and Stellaria media L. leaves. Pak. J. Bot. 54(4): 1517-1521.

Regards

Reviewer #2: - In Materials & Methods, authors explained that 152 genotypes selected from 760 genotypes based on the results of Kazemi alamuti et al. [26]. It is better to explain in brief how and why these genotypes selected and present the genotypes name, source/origin (if applicable) as a supplementary Table. I would appreciate to see official reference numbers for all accessions so that they can be order from reference gene banks and benefit for the entire pomegranate scientists community.

- In Materials & Methods, section “Investigation of morphological characteristics”: explain how many plants per genotypes evaluated? Some information about the field? Are there any statistical design? Or just sampled from a tree in a collection site? Please clarify it.

- Line 124, page 6: “The pH measurement was performed using a digital pH meter (Metrohm model) at 21 °C”, pH of what? Clearly explain.

- Fig 4. Spearman correlation matrix of the traits. This figure is difficult for reader to well understanding the relationship between traits. It is recommended to summarized in a Table.

- I strongly recommended to present a Table about some statistical parameters for all measured traits, like as mean, maximum, minimum, standard deviation and coefficient of variation (CV). This can be better explain the amount of variation in the studied germplasm.

- Are there any ANOVA analysis for traits?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: PROF. DR. NAQIB ULLAH KHAN

Reviewer #2: Yes: Reza Talebi

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear Roland Paile Bendaña

We would like to thank you for your email. I apologize for the delay in replying to your email. I could not send an email during this period due to the lack of internet access.

To resolve the issue mentioned in the email, all data are fully available without restriction, and we confirm that manuscript and Supporting Information files contain "minimal data set" to reach the conclusions drawn in the manuscript with related methods, and any additional data required to replicate the reported study findings in their entirety.

Kind regards,

Mehrshad Zeinalabedini

Dear Dr. Mehdi Rahimi,

We would like to thank you and the reviewers for constructive assessment of our manuscript entitled "First assessment of Iranian pomegranate germplasm using targeted metabolites and morphological traits to develop the core collection and modeling of the current and future spatial distribution under climate change conditions". We are pleased that all reviewers have found our article interesting. The authors greatly acknowledge the constructive comments made by the two reviewers. We have now revised the manuscript according to reviewers' comments, and a point-by-point response is submitted. Further, we confirmed that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Besides, the authors received no specific funding for this work.

We appreciate you for considering the revised version of the manuscript and look forward to receiving your decision.

Sincerely,

Mehrshad Zeinalabedini

Mehrshad Zeinalabedini, PhD

Agricultural Biotechnology Research Institute of Iran (www.abrii.ac.ir)

Mahdasht Road, Karaj, Iran. P.O. Box: 31535-1897

Tel: +98 (261) 2703536

Fax: +98 (261) 2704539

Email: mzeinolabedini@abrii.ac.ir

Answers to editor comments

Ref: PONE-D-22-06916

Title: First assessment of Iranian pomegranate germplasm using targeted metabolites and morphological traits to develop the core collection and modeling of the current and future spatial distribution under climate change conditions

Journal: Plos One

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Re: The format was checked and adjusted based on the editorial comments.

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

Re: This project was supported by the Agricultural Biotechnology Research Institute of Iran, ABRII07-05-05-92117. We revised this part based on the reviewer comment.

3. Thank you for stating the following financial disclosure:

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. At this time, please address the following queries:

Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. State what role the funders took in the study. If the funders had no role in your study, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If any authors received a salary from any of your funders, please state which authors and which funders. If you did not receive any funding for this study, please state: "The authors received no specific funding for this work." Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Re: we amended the requested statements in the cover letter based on the editorial comments.

4. Thank you for stating the following in your Competing Interests section:

I have read the journal's policy and the authors of this manuscript have the following competing interests

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

This information should be included in your cover letter; we will change the online submission form on your behalf.

Re: we amended the requested statements based on the editorial comments.

5. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

Re: The data set used in this study was presented in Supplementary Table 1 (S1 Table).

6. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

Re: ORCID iD for Mehrshad Zeinalabedini as the corresponding author is 0000-0002-34364334.

7. We note that Figures 1-3 and 13-14 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figures 1-3 and 13-14 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

Re: Figures 1-3 and 13-14 were designed by the free software, Diva-GIS (available at: http://www.diva-gis.org/climate; accessed on 4th October 2004) and MAXENT (https://biodiversityinformatics.amnh.org/open_source/maxent/) to construct the maps by the authors and had no copyright.

8.

The authors have declared that no competing interests exist.

Answers to Reviewers comments

Reviewer #1

1. What is novelty in the abstract? It needs improvement.

Re: Pomegranate core collection was established for the first time in Iran by combining morphological and metabolic data. Also, the impact of future climatic conditions (until the middle of the century) on the geographical distribution of pomegranate had not been investigated to date, which was predicted in this study. This information will help us identify the most suitable places for orchard construction in the future.

2. Reference should be according to journal format

Re: References were formatted according to the NLM/ICMJE style (the journal format).

4. Line 302 “The analysis of Spearman coefficient of correlation between morphological and metabolite traits was showed antioxidant activity correlated positively with total phenol”. Rephrase sentence.

Re: it was revised.

5. Line 312. “also reported there was a negative correlation”. Rephrase the sentence..

Re: The sentence was rephrased.

5. Do add the following latest references in discussion part for justification of your results, please.

Zarei A (2017). Biochemical and pomological characterization of pomegranate accessions in fars province of Iran. SABRAO J. Breed. Genet. 49(2): 155–167.

Tarinta T, Chanthai S, Lertrat K, Nawata E, Techawongstien S (2020). Identification of the secondary metabolite capsiate in Capsicum germplasm accessions. SABRAO J. Breed. Genet. 52(2):144–157.

Upadyshev MT (2022). Apple cultivars and rootstocks assay for the identification of diverse viruses and healthy genotypes for breeding. SABRAO J. Breed. Genet. 54(1): 79-87. http://doi.org/10.54910/sabrao2022.54.1.8.

Motyleva SM, Medvedev SM, Morozova NG, Kulikov IM (2021). Leaf micromorphological and biochemical features of scab disease in immune and moderately resistant columnar apple (Malus domestica) cultivars. SABRAO J. Breed. Genet. 53(3): 352-366.

Hong-Qun, L. I., Li-Gang, X. I. N. G., & Xie-Ping, S. U. N. (2022). Predicting the potential distribution of Taxus wallichiana var. Mairei under climate change in China using maxent modeling. Pak. J. Bot. 54(4): 1305-1310.

Ahmad, N., Shakil, A., Shinwari, Z. K., Ahmad, I., & Wahab, A. (2022). Phytochemical study and antimicrobial activities of extracts and its derived fractions obtained from Berberis vulgaris L. and Stellaria media L. leaves. Pak. J. Bot. 54(4): 1517-1521.

Re: Some of these articles were added in the results and discussion section, but we did not have access to the full article of some of them. As a result, we were unable to study them and add them to our article.

Reviewer #2:

- In Materials & Methods, authors explained that 152 genotypes selected from 760 genotypes based on the results of Kazemi alamuti et al. [26]. It is better to explain in brief how and why these genotypes selected and present the genotypes name, source/origin (if applicable) as a supplementary Table. I would appreciate to see official reference numbers for all accessions so that they can be order from reference gene banks and benefit for the entire pomegranate scientists community.

Re: The genotypes in this study were selected based on the previous results of our different studies (Kazemi alamuti et al. 2012; Mousavi Derazmahalleh et al. 2013; Razi et al. 2021), which were performed on various objects e.g. genetic diversity, population genetic etc. of Yazd pomegranate national germplasm. The name and origin of genotypes also was presented in S1 Table based on the existing codes of Iranian pomegranate germplasm.

- In Materials & Methods, section “Investigation of morphological characteristics”: explain how many plants per genotypes evaluated? Some information about the field? Are there any statistical design? Or just sampled from a tree in a collection site? Please clarify it.

Re: The number of plants for evaluating each genotype was three individual from which eight samples were harvested.

In this collection, four trees per genotype have been cultivated in five blocks in an area of 19 hectares. Information on the geographical location and climatic conditions of the site of collection was mentioned in the article.

- Line 124, page 6: “The pH measurement was performed using a digital pH meter (Metrohm model) at 21 °C”, pH of what? Clearly explain.

Re: pH of pomegranate aril juice was measured.

- Fig 4. Spearman correlation matrix of the traits. This figure is difficult for reader to well understanding the relationship between traits. It is recommended to summarized in a Table.

Re: Another figure, which includes the correlation coefficient values, replaced this figure. In the new figure, determining the correlation through both the values of the correlation coefficient and the color spectrum will make it easier for the reader to understand the correlation between traits.

- I strongly recommended to present a Table about some statistical parameters for all measured traits, like as mean, maximum, minimum, standard deviation and coefficient of variation (CV). This can be better explain the amount of variation in the studied germplasm.

Re: Descriptive statistics of biochemical traits (minimum, maximum, mean, and coefficient of variation) of 152 pomegranate genotypes were presented in Table 2.

The morphological features studied were qualitative traits that were scored and evaluated.

- Are there any ANOVA analysis for traits?

Re: there was no ANOVA analysis for traits in this study.

Attachments
Attachment
Submitted filename: response to reviewers.docx
Decision Letter - Mehdi Rahimi, Editor

PONE-D-22-06916R1First assessment of Iranian pomegranate germplasm using targeted metabolites and morphological traits to develop the core collection and modeling of the current and future spatial distribution under climate change conditionsPLOS ONE

Dear Dr. Zeinalabedini,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 27 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mehdi Rahimi, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: A Confusion:

Its not clear that the Authors incorporated or not the below suggested References, and 2/3 files of the Article are merged, and it not also clear that which one is revised version, please.

6. Do add the following latest references in discussion part for justification of your results, please.

Zarei A (2017). Biochemical and pomological characterization of pomegranate accessions in fars province of Iran. SABRAO J. Breed. Genet. 49(2): 155–167.

Tarinta T, Chanthai S, Lertrat K, Nawata E, Techawongstien S (2020). Identification of the secondary metabolite capsiate in Capsicum germplasm accessions. SABRAO J. Breed. Genet. 52(2):144–157.

Upadyshev MT (2022). Apple cultivars and rootstocks assay for the identification of diverse viruses and healthy genotypes for breeding. SABRAO J. Breed. Genet. 54(1): 79-87. http://doi.org/10.54910/sabrao2022.54.1.8.

Motyleva SM, Medvedev SM, Morozova NG, Kulikov IM (2021). Leaf micromorphological and biochemical features of scab disease in immune and moderately resistant columnar apple (Malus domestica) cultivars. SABRAO J. Breed. Genet. 53(3): 352-366.

Hong-Qun, L. I., Li-Gang, X. I. N. G., & Xie-Ping, S. U. N. (2022). Predicting the potential distribution of Taxus wallichiana var. Mairei under climate change in China using maxent modeling. Pak. J. Bot. 54(4): 1305-1310.

Ahmad, N., Shakil, A., Shinwari, Z. K., Ahmad, I., & Wahab, A. (2022). Phytochemical study and antimicrobial activities of extracts and its derived fractions obtained from Berberis vulgaris L. and Stellaria media L. leaves. Pak. J. Bot. 54(4): 1517-1521.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: PROF. DR. NAQIB Ullah KHAN

Reviewer #2: Yes: Reza Talebi

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: PONE-22-06916 - Review Report - May 31, 2022.doc
Revision 2

Dear Dr. Mehdi Rahimi,

Dear Dr. Mehdi Rahimi,

Thank you for giving me the opportunity to submit a revised draft of my manuscript titled "First assessment of Iranian pomegranate germplasm using targeted metabolites and morphological traits to develop the core collection and modeling of the current and future spatial distribution under climate change conditions”. I appreciate the time and effort that you and the reviewers have dedicated to providing your valuable feedback on our manuscript. I hope the manuscript after careful revisions meet PLOS ONE’s publication criteria.

I appreciate you for considering the revised version of the manuscript and look forward to receiving your decision.

Sincerely,

Mehrshad Zeinalabedini

Mehrshad Zeinalabedini, PhD

Agricultural Biotechnology Research Institute of Iran (www.abrii.ac.ir)

Mahdasht Road, Karaj, Iran. P.O. Box: 31535-1897

Tel: +98 (261) 2703536

Fax: +98 (261) 2704539

Email: mzeinolabedini@abrii.ac.ir

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Mehdi Rahimi, Editor

PONE-D-22-06916R2First assessment of Iranian pomegranate germplasm using targeted metabolites and morphological traits to develop the core collection and modeling of the current and future spatial distribution under climate change conditionsPLOS ONE

Dear Dr. Zeinalabedini,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 09 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mehdi Rahimi, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: PROF. DR. NAQIB ULLAH KHAN

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: SABRAO-J-Breed-Genet-533-352-366-MOTYLEVA.pdf
Revision 3

Dear Richard Ibañez Dilla

Many thanks for your email informing us to revise our manuscript.

We addressed the following issues.

1. If possible, please upload an updated file showing your changes either highlighted or using track changes. This should be uploaded as a Revised Manuscript w/tracked changes, file type. Please follow this link for more information: http://blogs.PLOS.org/everyone/2011/05/10/how-to-submit-your-revised-manuscript/

Re. In response to this issue, it is necessary to explain that in the file "Response to reviewers" that we sent the last time, we stated that since there was no change in the manuscript, we uploaded two files 'Response to Reviewers' and 'Manuscript'.

We upload new file "revised manuscript with track changes".

2. Please amend the manuscript submission data (via Edit Submission) to include all the authors.

Re: we amended the manuscript submission data to include all the authors

3. Please amend your list of authors on the manuscript to ensure that each author is linked to an affiliation.

Re: we amended our list of authors on the manuscript so that each author is linked to an affiliation.

We hope that we have satisfactory tackled all issues raised and that the manuscript is now well suited for publication.

We appreciate you for considering the revised version of the manuscript and look forward to receiving your decision.

Sincerely,

Mehrshad Zeinalabedini

Attachments
Attachment
Submitted filename: response to reviewers.docx
Decision Letter - Mehdi Rahimi, Editor

First assessment of Iranian pomegranate germplasm using targeted metabolites and morphological traits to develop the core collection and modeling of the current and future spatial distribution under climate change conditions

PONE-D-22-06916R3

Dear Dr. Zeinalabedini,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mehdi Rahimi, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Mehdi Rahimi, Editor

PONE-D-22-06916R3

First assessment of Iranian pomegranate germplasm using targeted metabolites and morphological traits to develop the core collection and modeling of the current and future spatial distribution under climate change conditions

Dear Dr. Zeinalabedini:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Associate Prof. Mehdi Rahimi

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .